---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-007513"
form_type: "8-K"
ticker: "PACB"
cik: "0001299130"
company_name: "PACIFIC BIOSCIENCES OF CALIFORNIA, INC."
filed_at: "2023-01-27T23:59:59+00:00"
generated_at: "2026-06-20T07:05:02.472835+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PacBio prices 17.5M-share offering at $10/shr; expected net proceeds ~$189.2M

## Summary
- Sold 17.5M shares plus full exercise of underwriter option for 2.625M additional shares at $10.00 per share.
- Gross proceeds ~$175M before option; net proceeds after discounts/expenses expected ~$189.2M.
- Net proceeds to fund R&D, commercial infrastructure, working capital, and potential acquisitions.
- Underwriters include Goldman Sachs, Morgan Stanley, Cowen, and Allen & Company; offering closed January 27, 2023.

## SEC filing metadata
- accession: 0001104659-23-007513
- form_type: 8-K
- ticker: PACB
- cik: 0001299130
- company_name: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- filed_at: 2023-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/0001104659-23-007513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/tm234462d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-007513
- JSON: https://secwatch.observer/filing/0001104659-23-007513.json
- Plain text: https://secwatch.observer/filing/0001104659-23-007513.txt

## Key facts
- Material Agreements
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein valued at approximately $189.2 million (effective 2023-01-24).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein
  - Value: approximately $189.2 million
  - Effective: 2023-01-24
  source text: On January 24, 2023, Pacific Biosciences of California, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, and Cowen and Company, LLC, as representatives of the several underwriters named therein
  evidence_url: https://www.sec.gov/Archives/edgar/data/1299130/000110465923007513/0001104659-23-007513-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.